Importance of plasma membrane dynamics in chemical-induced carcinogenesis

Recent Patents on Anti-Cancer Drug Discovery

Volumn 6, Issue 3, 2011, Pages 347-353

  Tekpli, Xavier ^a   Holme, Jørn A ^b   Sergent, Odile ^a   Lagadic Gossmann, Dominique ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Carcinogenesis; Caveolin; Cell death; Dna damage; Membrane alteration; Reactive oxygen species

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTHRACENE DERIVATIVE; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CADMIUM; CAVEOLIN 1; CHLORPHENOTANE; CIGARETTE SMOKE; CISPLATIN; COPPER; DNA; DOXORUBICIN; ENDOSULFAN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN RECEPTOR; LINDANE; LIPID; MERCURY; MICROCYSTIN; PHENANTHRACENE; POLYCHLORINATED BIPHENYL; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; THALLIUM; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; ZINC;

ANTINEOPLASTIC ACTIVITY; BILAYER MEMBRANE; CANCER SCREENING; CARCINOGENESIS; CARCINOGENICITY; CELL FUNCTION; CELL MEMBRANE; DNA DAMAGE; ENZYME INDUCTION; GENE MUTATION; GENOTOXICITY; HUMAN; LIPID PEROXIDATION; LIPID RAFT; MEMBRANE DAMAGE; MEMBRANE FLUIDITY; MEMBRANE STRUCTURE; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; PATENT; PERMEABILITY BARRIER; POLLUTANT; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOMECHANICS; CARCINOGENS; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LIPID PEROXIDATION; MEMBRANE FLUIDITY; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES;

EID: 80052324142     PISSN: 15748928     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489211796957784     Document Type: Review

References (72)

1. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993; 259: 1769-1771.
2. Ohta H, Yatomi Y, Sweeney EA, Hakomori S, Igarashi Y. A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-alpha in human neutrophils. FEBS Lett 1994; 355: 267-270.
3. Diomede L, Colotta F, Piovani B, Re F, Modest EJ, Salmona M. Induction of apoptosis in human leukemic cells by the ether lipid 1- octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int J Cancer 1993; 53: 124-130.
4. Martin SJ, Bradley JG, Cotter TG. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 1990; 79: 448-453.
5. Haug JS, Goldner CM, Yazlovitskaya EM, Voziyan PA, Melnykovych G. Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: Effect of phosphatidylcholine. Biochim Biophys Acta 1994; 1223: 133-140.
6. Ohizumi H, Masuda Y, Nakajo S, Sakai I, Ohsawa S, Nakaya K. Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J Biochem 1995; 117: 11-13.
7. Yamamoto M, Honjo T, Paumen MB. [Fatty acids-induced apoptosis]. Tanpakushitsu Kakusan Koso 1997; 42: 1637-1643.
8. Rebillard A, Tekpli X, Meurette O, Sergent O, LeMoigne-Muller G, Vernhet L, et al. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res 2007; 67: 7865-7874.
9. Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S. Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist Updat 2005; 8: 5-14.
10. Kinnunen PK. On the principles of functional ordering in biological membranes. Chem Phys Lipids 1991; 57: 375-399.
11. Gorria M, Tekpli X, Sergent O, Huc L, Gaboriau F, Rissel M, et al. Membrane fluidity changes are associated with benzo[a]pyreneinduced apoptosis in F258 cells: Protection by exogenous cholesterol. Ann N Y Acad Sci 2006; 1090: 108-112.
12. Tekpli X, Rissel M, Huc L, Catheline D, Sergent O, Rioux V, et al. Membrane remodeling, an early event in benzo[a]pyrene-induced apoptosis. Toxicol Appl Pharmacol 2010; 243: 68-76.
13. Kallimanis A, Frillingos S, Drainas C, Koukkou AI. Taxonomic identification, phenanthrene uptake activity, and membrane lipid alterations of the PAH degrading Arthrobacter sp. strain Sphe3. Appl Microbiol Biotechnol 2007; 76: 709-717.
14. Antunes-Madeira MC, Madeira VM. Membrane fluidity as affected by the organochlorine insecticide DDT. Biochim Biophys Acta 1990; 1023: 469-474.
15. Antunes-Madeira MC, Madeira VM. Membrane fluidity as affected by the insecticide lindane. Biochim Biophys Acta 1989; 982: 161-166.
16. Gutierrez-Ocana MT, Senar S, Perez-Albarsanz MA, Recio MN. Lindane-induced modifications to membrane lipid structure: Effect on membrane fluidity after subchronic treatment. Biosci Rep 1992; 12: 303-311.
17. Videira RA, Antunes-Madeira MC, Madeira VM. Differential effects induced by alpha- and beta-endosulfan in lipid bilayer organization are reflected in proton permeability. Biochim Biophys Acta 2002; 1564: 140-148.
18. Sicinska P, Bukowska B, Michalowicz J, Duda W. Damage of cell membrane and antioxidative system in human erythrocytes incubated with microcystin-LR in vitro. Toxicon 2006; 47: 387-397.
19. Hannan SE, Harris JO, Sheridan NP, Patel JM. Cigarette smoke alters plasma membrane fluidity of rat alveolar macrophages. Am Rev Respir Dis 1989; 140: 1668-16673.
20. Sandal S, Yilmaz B, Chen CH, Carpenter DO. Comparative effects of technical toxaphene, 2,5-dichloro-3-biphenylol and octabromodiphenylether on cell viability, [Ca2+]i levels and membrane fluidity in mouse thymocytes. Toxicol Lett 2004; 151: 417-428.
21. Yilmaz B, Sandal S, Chen CH, Carpenter DO. Effects of PCB 52 and PCB 77 on cell viability, [Ca(2+)](i) levels and membrane fluidity in mouse thymocytes. Toxicology 2006; 217: 184-193.
22. Verstraeten SV. Relationship between thallium(I)-mediated plasma membrane fluidification and cell oxidants production in Jurkat T cells. Toxicology 2006; 222: 95-102.
23. Garcia JJ, Martinez-Ballarin E, Millan-Plano S, Allue JL, Albendea C, Fuentes L, et al. Effects of trace elements on membrane fluidity. J Trace Elem Med Biol 2005; 19: 19-22.
24. Eum SY, Andras I, Hennig B, Toborek M. NADPH oxidase and lipid raft-associated redox signaling are required for PCB153- induced upregulation of cell adhesion molecules in human brain endothelial cells. Toxicol Appl Pharmacol 2009; 240: 299-305.
25. Parton RG. Caveolae and caveolins. Curr Opin Cell Biol 1996; 8: 542-548.
26. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992; 68: 673-682.
27. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG, Jr., Ishikawa Y. Caveolin is an activator of insulin receptor signaling. J Biol Chem 1998; 273: 26962-26968.
28. Shaul PW, Anderson RG. Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998; 275: L843-L851.
29. Stahlhut M, Sandvig K, van Deurs B. Caveolae: Uniform structures with multiple functions in signaling, cell growth, and cancer. Exp Cell Res 2000; 261: 111-118.
30. Park, S.C., Kim, J.C., Rhim, J.H. Use of caveolin-1 as biomarker diagnosing wound healing ability after ophthalmological surgery and method for diagnosing wound healing ability using the same. WO2010093209 (2010).
31. Oesterling E, Toborek M, Hennig B. Benzo[a]pyrene induces intercellular adhesion molecule-1 through a caveolae and aryl hydrocarbon receptor mediated pathway. Toxicol Appl Pharmacol 2008; 232: 309-316.
32. Lim EJ, Smart EJ, Toborek M, Hennig B. The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. Am J Physiol Heart Circ Physiol 2007; 293: H3340-H347.
33. Brandenberger C, Rothen-Rutishauser B, Blank F, Gehr P, Muhlfeld C. Particles induce apical plasma membrane enlargement in epithelial lung cell line depending on particle surface area dose. Respir Res 2009; 10: 22.
34. Brandenberger C, Muhlfeld C, Ali Z, Lenz AG, Schmid O, Parak WJ, et al. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small 2010; 6: 1669-16678.
35. Whitlock JP, Jr. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 1999; 39: 103-125.
36. Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor crosstalks with multiple signal transduction pathways. Biochem Pharmacol 2009; 77: 713-722.
37. Sato S, Shirakawa H, Tomita S, Ohsaki Y, Haketa K, Tooi O, et al. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicol Appl Pharmacol 2008; 229: 10-19.
38. Iwano S, Nukaya M, Saito T, Asanuma F, Kamataki T. A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 2005; 335: 220-226.
39. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein- 1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000; 14: 2819-2830.
40. Carvajal-Gonzalez JM, Mulero-Navarro S, Roman AC, Sauzeau V, Merino JM, Bustelo XR, et al. The dioxin receptor regulates the constitutive expression of the vav3 proto-oncogene and modulates cell shape and adhesion. Mol Biol Cell 2009; 20: 1715-1727.
41. Watzl C, Long EO. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J Exp Med 2003; 197: 77-85.
42. Gorria M, Huc L, Sergent O, Rebillard A, Gaboriau F, Dimanche- Boitrel MT, et al. Protective effect of monosialoganglioside GM1 against chemically induced apoptosis through targeting of mitochondrial function and iron transport. Biochem Pharmacol 2006; 72: 1343-1353.
43. Bartosz G. Total antioxidant capacity. Adv Clin Chem 2003; 37: 219-292.
44. Ghosh C, Dick RM, Ali SF. Iron/ascorbate-induced lipid peroxidation changes membrane fluidity and muscarinic cholinergic receptor binding in rat frontal cortex. Neurochem Int 1993; 23: 479-484.
45. Charruyer A, Grazide S, Bezombes C, Muller S, Laurent G, Jaffrezou JP. UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently on a nuclear signal. J Biol Chem 2005; 280: 19196-19204.
46. Duffaud F, Orsiere T, Baciuchka-Palmaro M, Digue L, Favre R, Botta A. [Doxorubicin and cisplatin genotoxicity: Search for a real indication using the micronucleus test]. Ann Biol Clin (Paris) 1998; 56: 183-187.
47. Jendrossek V, Handrick R. Membrane targeted anticancer drugs: Potent inducers of apoptosis and putative radiosensitisers. Curr Med Chem Anticancer Agents 2003; 3: 343-353.
48. Filipak Neto F, Zanata SM, Silva de Assis HC, Nakao LS, Randi MA, Oliveira Ribeiro CA. Toxic effects of DDT and methyl mercury on the hepatocytes from Hoplias malabaricus. Toxicol In vitro 2008; 22: 1705-1713.
49. Nourissat P, Travert M, Chevanne M, Tekpli X, Rebillard A, Le Moigne-Muller G, et al. Ethanol induces oxidative stress in primary rat hepatocytes through the early involvement of lipid raft clustering. Hepatology 2008; 47: 59-70.
50. Sergent O, Morel I, Chevanne M, Cillard P, Cillard J. Oxidative stress induced by ethanol in rat hepatocyte cultures. Biochem Mol Biol Int 1995; 35: 575-583.
51. Hossain K, Akhand AA, Kawamoto Y, Du J, Takeda K, Wu J, et al. Caspase activation is accelerated by the inhibition of arseniteinduced, membrane rafts-dependent Akt activation. Free Radic Biol Med 2003; 34: 598-606.
52. Gniadecki R, Christoffersen N, Wulf HC. Cholesterol-rich plasma membrane domains (lipid rafts) in keratinocytes: Importance in the baseline and UVA-induced generation of reactive oxygen species. J Invest Dermatol 2002; 118: 582-588.
53. Gorria M, Tekpli X, Rissel M, Sergent O, Huc L, Landvik N, et al. A new lactoferrin- and iron-dependent lysosomal death pathway is induced by benzo[a]pyrene in hepatic epithelial cells. Toxicol Appl Pharmacol 2008; 228: 212-224.
54. Erol A. Systemic DNA damage response and metabolic syndrome as a premalignant state. Curr Mol Med 2010; 10: 321-334.
55. Tekpli X, Rivedal E, Gorria M, Landvik NE, Rissel M, Dimanche- Boitrel MT, et al. The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis. Toxicol Appl Pharmacol 2010; 242: 231-240.
56. Langlois S, Cowan KN, Shao Q, Cowan BJ, Laird DW. Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes. Mol Biol Cell 2008; 19: 912-928.
57. Zatloukalova J, Svihalkova-Sindlerova L, Kozubik A, Krcmar P, Machala M, Vondracek J. Beta-Naphthoflavone and 3'-methoxy-4'- nitroflavone exert ambiguous effects on Ah receptor-dependent cell proliferation and gene expression in rat liver 'stem-like' cells. Biochem Pharmacol 2007; 73: 1622-1634.
58. Chramostova K, Vondracek J, Sindlerova L, Vojtesek B, Kozubik A, Machala M. Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells. Toxicol Appl Pharmacol 2004; 196: 136-148.
59. Dietrich C, Faust D, Budt S, Moskwa M, Kunz A, Bock KW, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicol Appl Pharmacol 2002; 183: 117-126.
60. Seveau S, Bierne H, Giroux S, Prevost MC, Cossart P. Role of lipid rafts in E-cadherin-- and HGF-R/Met--mediated entry of Listeria monocytogenes into host cells. J Cell Biol 2004; 166: 743-753.
61. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 2004; 279: 51630-51646.
62. Razani B, Altschuler Y, Zhu L, Pestell RG, Mostov KE, Lisanti MP. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry 2000; 39: 13916-13924.
63. Timme TL, Goltsov A, Tahir S, Li L, Wang J, Ren C, et al. Caveolin- 1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene 2000; 19: 3256-3265.
64. Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A, et al. Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry 2001; 40: 3354-3362.
65. Koleske AJ, Baltimore D, Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci U S A 1995; 92: 1381-1385.
66. Engelman JA, Zhang X, Galbiati F, Volonte D, Sotgia F, Pestell RG, et al. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am J Hum Genet 1998; 63: 1578-1587.
67. Lisanti, M.P., Sotgia, F., Pestell, R.G. Therapeutics and methods for treating neoplastic diseases comprising determining the level of caveolin-1 and/or caveolin-2 in a stromal cell sample. WO2010096627 (2010).
68. Thompson, T.C. Methods for the treatment of neoplastic disorders with anti-caveolin Agents. US7666412 (2005).
69. Sergent O, Ekroos K, Lefeuvre-Orfila L, Rissel M, Forsberg GB, Oscarsson J, et al. Ximelagatran increases membrane fluidity and changes membrane lipid composition in primary human hepatocytes. Toxicol In vitro 2009; 23: 1305-1310.
70. Kay, H. Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods. US20080286316 (2007).
71. Jigami, Y., Yoko, O.T., Umemura, M., Fujita, M. Genes and proteins involved in lipid remodeling of gpi-anchored proteins and the use thereof. US20080233608 (2008).
72. Pedrol, D., Carles, J. Use of docosahexaenoic glycerides for the treatment of tumorous diseases. US20090318553 (2009).